1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Demant A/S
  6. Summary
    DEMANT   DK0060738599

DEMANT A/S

(DEMANT)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Copenhagen
05/19/2022 05/20/2022 05/23/2022 05/24/2022 05/25/2022 Date
283.9(c) 294.7(c) 286.4(c) 286.2(c) 282(c) Last
451 700 446 103 295 252 468 393 351 916 Volume
-3.20% +3.80% -2.82% -0.07% -1.47% Change
More quotes
Estimated financial data (e)
Sales 2022 20 070 M 2 890 M 2 890 M
Net income 2022 2 651 M 382 M 382 M
Net Debt 2022 9 730 M 1 401 M 1 401 M
P/E ratio 2022 24,3x
Yield 2022 -
Sales 2023 21 606 M 3 111 M 3 111 M
Net income 2023 2 996 M 431 M 431 M
Net Debt 2023 9 243 M 1 331 M 1 331 M
P/E ratio 2023 20,8x
Yield 2023 -
Capitalization 62 147 M 8 950 M 8 950 M
EV / Sales 2022 3,58x
EV / Sales 2023 3,30x
Nbr of Employees 18 116
Free-Float 38,8%
More Financials
Company
Demant A/S is the world's 2nd leading producer of audio products. Net sales break down by family of products as follows: - tailor-made hearing aids (80.9%): hearing aid and audiphones manufactured under the Oticon, Bernafon, Philips and Sonic brands; - diagnostic products (9.9%): audiometers sold under the Maico and Interacoustics brands; - business communication solutions (6.4%); - hearing implants (2.8%):... 
More about the company
Ratings of Demant A/S
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about DEMANT A/S
05/03GLOBAL MARKETS LIVE : BP, Pfizer, Expedia, Citigroup, Amazon...
05/03TRANSCRIPT : Demant A/S, 4 Months 2022 Interim Management Statement Call, May 03, 2022
CI
05/03Hearing Aid Group Demant Affirms FY22 Guidance Despite Russia Hit
MT
05/03DEMANT A/S : Interim Management Statement covering Q1 2022
AQ
05/03Demant A/S Provides Earnings Guidance for the Full Year 2022
CI
05/03DEMANT A/S : 1st quarter results
CO
04/27TRANSCRIPT : Demant A/S - Special Call
CI
04/27Hearing Care Group Demant To Sell Hearing Implants Unit For $121 Million
MT
04/27DEMANT A/S : Divestment of Hearing Implants
AQ
04/25DEMANT A/S : Completion of capital reduction
AQ
03/25DEMANT A/S : Investor news - disclosure of historical quarterly figures
AQ
03/10DEMANT A/S : Decisions of annual general meeting
AQ
03/10DEMANT A/S : Extension of Demant's Executive Board
AQ
03/10Demant A/S Announces Appoints of Arne Boye Nielsen and Niels Wagner to Executive Board,..
CI
03/10DEMANT A/S : Proxy Statments
CO
More news
News in other languages on DEMANT A/S
05/27BOLSA DE MADRID : ┐Final de la serie descendente?
05/27Fin de série baissière ?
05/27AVIS D'ANALYSTES DU JOUR : Alstom, Faurecia, Unibail, Pernod Richard, JCDecaux, Bolloré, R..
05/17Sonova steigert Umsatz und legt beim Marktanteil weiter zu
05/03BOLSA DE MADRID : Dedo gordo y cuenta regresiva
More news
Analyst Recommendations on DEMANT A/S
More recommendations
Chart DEMANT A/S
Duration : Period :
Demant A/S Technical Analysis Chart | DEMANT | DK0060738599 | MarketScreener
Technical analysis trends DEMANT A/S
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Last Close Price 282,00 DKK
Average target price 308,46 DKK
Spread / Average Target 9,38%
EPS Revisions
Managers and Directors
S°ren Nielsen President & Chief Executive Officer
RenÚ Schneider Chief Financial Officer
Niels Bj°rn Christiansen Chairman
Anja Madsen Independent Director
Kristian Villumsen Independent Director
Sector and Competitors
1st jan.Capi. (M$)
DEMANT A/S-15.85%8 950
SONOVA HOLDING AG-4.42%21 846
STRAUMANN HOLDING AG-38.20%19 952
COCHLEAR LIMITED1.10%10 281
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.-4.88%3 138
ANGELALIGN TECHNOLOGY INC.-50.60%2 649